TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34028342

Group type: EXPERIMENTAL
Intervention: Expressive writing (negative alcohol-related event)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control writing condition (first day of college)
Number of subjects: 0
Study: 36250668

Group type: EXPERIMENTAL
Intervention: Mitral surgery
Number of subjects: 142

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 142
Study: 32118508

Group type: EXPERIMENTAL
Intervention: Phonophoretic application of a nanoemulsion incorporating glucosamine and chondroitin sulfate (NANO‐CG) associated with kinesiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 34487086

Group type: EXPERIMENTAL
Intervention: 2-hour Oral Glucose Tolerance Test (OGTT)
Number of subjects: 43
Study: 33143707

Group type: EXPERIMENTAL
Intervention: LLINs and Bti
Number of subjects: 11846

Group type: EXPERIMENTAL
Intervention: LLINs and CEM
Number of subjects: 11846

Group type: EXPERIMENTAL
Intervention: LLINs combined with Bti and CEM
Number of subjects: 11846

Group type: COMPARATOR
Intervention: LLINs only
Number of subjects: 11846
Study: 35360550

Group type: EXPERIMENTAL
Intervention: AI film reading system
Number of subjects: 104

Group type: COMPARATOR
Intervention: Radiologists
Number of subjects: 104
Study: 33934519

Group type: EXPERIMENTAL
Intervention: Durlobactam 4 g (supratherapeutic dose)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus moxifloxacin 400 mg (open-label)
Number of subjects: 0
Study: 33313732

Group type: EXPERIMENTAL
Intervention: Low-dose chiropractic care (1 to 5 visits)
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Higher-dose chiropractic care (8 to 12 visits)
Number of subjects: 766

Group type: EXPERIMENTAL
Intervention: Monthly chiropractic chronic pain management for 10 months
Number of subjects: 766

Group type: COMPARATOR
Intervention: No scheduled chiropractic visits for 10 months
Number of subjects: 766
Study: 34129088

Group type: EXPERIMENTAL
Intervention: Laparoscopic complete mesocolic excision (CME)
Number of subjects: 372

Group type: COMPARATOR
Intervention: Laparoscopic non-complete mesocolic excision (NCME)
Number of subjects: 372
Study: 33832432

Group type: EXPERIMENTAL
Intervention: Personalized prescribing report from a medical regulatory authority (MRA)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Personal warning letter from the MRA
Number of subjects: 272

Group type: COMPARATOR
Intervention: Personal phone call from an MRA pharmacist
Number of subjects: 272

Group type: COMPARATOR
Intervention: Personal phone call from an MRA physician
Number of subjects: 272

Group type: COMPARATOR
Intervention: All groups (including control)
Number of subjects: 272
Study: 34086481

Group type: EXPERIMENTAL
Intervention: Induction neoadjuvant hormonal therapy (HT) with fulvestrant 500 mg (with or without goserelin)
Number of subjects: 258

Group type: EXPERIMENTAL
Intervention: Fulvestrant 500 mg plus palbociclib
Number of subjects: 258

Group type: COMPARATOR
Intervention: Fulvestrant 500 mg plus placebo
Number of subjects: 258
Study: 32416026

Group type: EXPERIMENTAL
Intervention: HAF-Lidocaine (HA filler with 0.3% lidocaine)
Number of subjects: 62

Group type: COMPARATOR
Intervention: HAF (HA filler without lidocaine)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: HAF-Lidocaine
Number of subjects: 62
Study: 36454365

Group type: EXPERIMENTAL
Intervention: Moderate-intensity PA intervention (at least 1 hour/week of supervised strenuous activity)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Isocaloric dietary intervention mainly based on plant-foods
Number of subjects: 234

Group type: COMPARATOR
Intervention: General recommendations on healthy dietary and PA patterns
Number of subjects: 234

Group type: COMPARATOR
Intervention: Both dietary and PA interventions
Number of subjects: 234
Study: 32712322

Group type: EXPERIMENTAL
Intervention: Autofill void trial (group A)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Backfill void trial (group B)
Number of subjects: 82
Study: 32058628

Group type: EXPERIMENTAL
Intervention: Educational video on infant crying watched within 1 week of age during hospitalization at maternity wards.
Number of subjects: 2601

Group type: COMPARATOR
Intervention: Control group (no educational video).
Number of subjects: 2601

Group type: EXPERIMENTAL
Intervention: Educational video on infant crying for young mothers (<25 years).
Number of subjects: 2601
Study: 33821577

Group type: EXPERIMENTAL
Intervention: MNV3 group
Number of subjects: 83

Group type: COMPARATOR
Intervention: MNV1 control group
Number of subjects: 83

Group type: COMPARATOR
Intervention: MNV2 control group
Number of subjects: 83
Study: 34956400

Group type: EXPERIMENTAL
Intervention: Fine nursing intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: General nursing (Control)
Number of subjects: 0
Study: 33128036

Group type: EXPERIMENTAL
Intervention: Liquid meal replacement combined with lifestyle intervention (INT)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Lifestyle intervention only (CON)
Number of subjects: 463
Study: 35897310

Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum SNK12 (50 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum SNK12 (150 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (dextrin)
Number of subjects: 0
Study: 33782036

Group type: EXPERIMENTAL
Intervention: Ramipril (1.25-10 mg/d)
Number of subjects: 269

Group type: COMPARATOR
Intervention: Non-RAS inhibition therapy
Number of subjects: 269

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 269
Study: 32781939

Group type: EXPERIMENTAL
Intervention: Carboxytherapy plus transcutaneous electrical nerve stimulation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Carboxytherapy plus interferential current
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Carboxytherapy plus Aussie current
Number of subjects: 75
Study: 36342618

Group type: EXPERIMENTAL
Intervention: RBX2660
Number of subjects: 267

Group type: COMPARATOR
Intervention: Blinded Placebo
Number of subjects: 267
Study: 34529065

Group type: EXPERIMENTAL
Intervention: Medication reconciliation at hospital admission
Number of subjects: 1702

Group type: COMPARATOR
Intervention: Standard, physician-acquired medication history (Control)
Number of subjects: 1702
Study: 33636242

Group type: EXPERIMENTAL
Intervention: Microneedle patch plus 5% topical lidocaine
Number of subjects: 16

Group type: COMPARATOR
Intervention: Patch without microneedles plus 5% topical lidocaine
Number of subjects: 16
Study: 35535436

Group type: EXPERIMENTAL
Intervention: Varenicline (VAR)
Number of subjects: 6653

Group type: EXPERIMENTAL
Intervention: Bupropion (BUP)
Number of subjects: 6653

Group type: EXPERIMENTAL
Intervention: Nicotine Replacement Therapy (NRT)
Number of subjects: 6653

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 6653

Group type: COMPARATOR
Intervention: All active treatments (VAR, BUP, NRT)
Number of subjects: 6653

Group type: EXPERIMENTAL
Intervention: Neuropsychiatric adverse events (NPSAEs)
Number of subjects: 6653
Study: 34623418

Group type: EXPERIMENTAL
Intervention: Current smokers
Number of subjects: 7983

Group type: EXPERIMENTAL
Intervention: Former smokers
Number of subjects: 7983

Group type: EXPERIMENTAL
Intervention: Prospective parallel group
Number of subjects: 7983

Group type: EXPERIMENTAL
Intervention: Current smokers at Year 4
Number of subjects: 7983

Group type: EXPERIMENTAL
Intervention: Former smokers at Year 4
Number of subjects: 7983

Group type: COMPARATOR
Intervention: Still smoking
Number of subjects: 7983

Group type: EXPERIMENTAL
Intervention: Smokers who quit
Number of subjects: 7983
Study: 32425111

Group type: EXPERIMENTAL
Intervention: Low-Na solution (112 mmol/L Na and 2% glucose)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard-Na solution (133 mmol/L Na and 1.5% glucose)
Number of subjects: 123
Study: 36253280

Group type: EXPERIMENTAL
Intervention: Ballistic resistance training
Number of subjects: 144

Group type: COMPARATOR
Intervention: Non-ballistic exercise rehabilitation
Number of subjects: 144
Study: 35176099

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) in dorsal decubitus position with lower limbs raised
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control (dorsal decubitus position with lower limbs raised without NMES)
Number of subjects: 37
Study: 33159002

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training (20 to 25 sessions of 45 minutes over 5 to 7 weeks)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Usual teaching
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Cogmed Working Memory Training
Number of subjects: 226
Study: 36280541

Group type: EXPERIMENTAL
Intervention: 360° virtual counselling environment (360°VCE)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Routine standard of care counselling
Number of subjects: 86
Study: 33385299

Group type: EXPERIMENTAL
Intervention: Rifaximin 400 mg twice daily for 6 months
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no rifaximin)
Number of subjects: 200
Study: 32218417

Group type: EXPERIMENTAL
Intervention: Boric highly mineralized bicarbonate sodium water
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Highly mineralized sulfate-bicarbonate sodium-magnesium water
Number of subjects: 90

Group type: COMPARATOR
Intervention: Basic treatment complex (dietary and proton pump inhibitor drugs)
Number of subjects: 90
Study: 35920065

Group type: EXPERIMENTAL
Intervention: Cladribine tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 0
Study: 32326256

Group type: EXPERIMENTAL
Intervention: Competitions 3-4
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All competitions except 2-4
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: All competitions
Number of subjects: 22
Study: 615245085

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) intralesional injection (0.58 mg/injection, up to eight injections)
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum (CCH) intralesional injection
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: CCH treatment of male partners
Number of subjects: 189
Study: 36493800

Group type: EXPERIMENTAL
Intervention: Audiovisual information delivery
Number of subjects: 90

Group type: COMPARATOR
Intervention: Verbal information delivery
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups (audiovisual and verbal)
Number of subjects: 90
Study: 33752420

Group type: EXPERIMENTAL
Intervention: Microlecture teaching method
Number of subjects: 84

Group type: COMPARATOR
Intervention: Traditional teaching method (control group)
Number of subjects: 84
Study: 32331460

Group type: EXPERIMENTAL
Intervention: Biofeedback Training (BT)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Smartphone-Delivered Biofeedback Training (SDBT)
Number of subjects: 159

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 159
Study: 36012033

Group type: EXPERIMENTAL
Intervention: EMG rehabilitation robot training
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard rehabilitation (Control Group)
Number of subjects: 0
Study: 33036660

Group type: EXPERIMENTAL
Intervention: MRI for prostate cancer screening
Number of subjects: 100
Study: 36104805

Group type: EXPERIMENTAL
Intervention: Communication intervention between clinical pharmacists and physicians
Number of subjects: 367

Group type: COMPARATOR
Intervention: Control group (no communication intervention)
Number of subjects: 367
Study: 34116919

Group type: EXPERIMENTAL
Intervention: Post-exercise hot water immersion (HWI)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Exercise-heat-acclimation (EHA)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Thermoneutral exercise (TNE)
Number of subjects: 27
Study: 32805428

Group type: EXPERIMENTAL
Intervention: Lipid-containing tear supplement (Systane Complete)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Non-lipid containing eye drop (Systane Ultra)
Number of subjects: 28
Study: 32673222

Group type: EXPERIMENTAL
Intervention: ITEC-CHF (telemonitoring program)
Number of subjects: 184
Study: 34700598

Group type: EXPERIMENTAL
Intervention: IMRT with ISBT boost (initial dose 50Gy with IMRT followed by 24.5Gy dose in 12 fractions)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: IMRT with ISBT boost
Number of subjects: 70

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 70
Study: 32130284

Group type: EXPERIMENTAL
Intervention: Anorganic xenograft added at the time of flapless, one-stage placement of a sloped-platform implant
Number of subjects: 0

Group type: COMPARATOR
Intervention: No graft
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (graft and no graft)
Number of subjects: 0
Study: 35045101

Group type: EXPERIMENTAL
Intervention: Safety promotion intervention (8 sessions)
Number of subjects: 91
Study: 33453095

Group type: EXPERIMENTAL
Intervention: Topical formulation (TF) - Product A
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (Product B)
Number of subjects: 100
Study: 34986381

Group type: EXPERIMENTAL
Intervention: Trastuzumab and left-sided RT (1270 patients)
Number of subjects: 3321

Group type: EXPERIMENTAL
Intervention: Trastuzumab and right-sided RT (1271 patients)
Number of subjects: 3321

Group type: EXPERIMENTAL
Intervention: Trastuzumab with no RT (780 patients)
Number of subjects: 3321
Study: 33972256

Group type: EXPERIMENTAL
Intervention: Etesevimab (2.5 to 50 mg/kg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 32852530

Group type: EXPERIMENTAL
Intervention: Fingolimod, 0.5 mg
Number of subjects: 1064

Group type: EXPERIMENTAL
Intervention: Fingolimod, 0.25 mg
Number of subjects: 1064

Group type: COMPARATOR
Intervention: Glatiramer acetate, 20 mg
Number of subjects: 1064
Study: 35313321

Group type: EXPERIMENTAL
Intervention: Diprospan group (0.5% ropivacaine plus Diprospan)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Control group (0.5% ropivacaine alone)
Number of subjects: 96
Study: 32473673

Group type: EXPERIMENTAL
Intervention: elexacaftor plus tezacaftor plus ivacaftor combination regimen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 36121560

Group type: EXPERIMENTAL
Intervention: Diary-supported (paper group; n=49)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: App-supported (app group; n=49)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Therapist-supported (therapist group; n=50)
Number of subjects: 148
Study: 33591125

Group type: EXPERIMENTAL
Intervention: Subacromial hyaluronate injection (2 mL, 20 mg, hyaluronate 1% (500 to 700 kDa))
Number of subjects: 51

Group type: COMPARATOR
Intervention: Physiotherapy (PT), three sessions per week for 12 weeks (totaling 36 sessions including rotator cuff activation exercises)
Number of subjects: 51
Study: 33211739

Group type: EXPERIMENTAL
Intervention: Coated packaging
Number of subjects: 10

Group type: COMPARATOR
Intervention: Ambient temperature without coated packaging
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coated packaging at 10°C
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Coated packaging at ambient temperature
Number of subjects: 10
Study: 35437111

Group type: EXPERIMENTAL
Intervention: Oral azacitidine (CC‐486)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32217152

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (GFD)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Urine samples on weekends
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Stool samples during weekdays
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Comparison of week 1 vs week 4 urine samples
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Patients with symptoms
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Correlation with blood samples
Number of subjects: 53
Study: 32293670

Group type: EXPERIMENTAL
Intervention: Social marketing strategies for recruitment (emails, flyers/posters, other sources, multiple sources)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Flyers/posters
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Multiple sources
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: Email
Number of subjects: 460
Study: 32964829

Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 0

Group type: COMPARATOR
Intervention: MAD
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study: 33560633

Group type: EXPERIMENTAL
Intervention: Wrist actigraphy for sleep efficiency (SE) and total sleep time (TST)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Wrist actigraphy for daytime activity ratio (DAR)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Wrist actigraphy for hourly activity counts
Number of subjects: 31
Study: 35961599

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 174

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 174
Study: 33682640

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Ivermectin
Number of subjects: 168

Group type: COMPARATOR
Intervention: Control (no specific control group mentioned)
Number of subjects: 168
Study: 32623343

Group type: EXPERIMENTAL
Intervention: Sushi roll technique
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 60
Study: 36055295

Group type: EXPERIMENTAL
Intervention: Dolutegravir-based ART (5 mg dispersible dolutegravir dosed according to WHO weight bands)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard of care (mainly protease inhibitor-based ART)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Dolutegravir-based ART
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 85
Study: 33306506

Group type: EXPERIMENTAL
Intervention: High-carbohydrate intake (% of energy/d)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: n-3 polyunsaturated fatty acids (n-3 PUFAs) intake (g/d)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Isoflavones intake (mg/d)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Methionine intake (mg/d)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Choline intake (mg/d)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Carbohydrates intake among rs738409 G-allele carriers
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs intake among rs738409 G-allele carriers
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Isoflavones intake among rs738409 G-allele carriers
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Methionine intake among rs738409 G-allele carriers
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Choline intake among rs738409 G-allele carriers
Number of subjects: 452
Study: 34415010

Group type: EXPERIMENTAL
Intervention: Pictorial warning label exposure
Number of subjects: 229
Study: 32914563

Group type: EXPERIMENTAL
Intervention: Phaco chop technique
Number of subjects: 66

Group type: COMPARATOR
Intervention: Drill-and-crack technique
Number of subjects: 66
Study: 32881797

Group type: EXPERIMENTAL
Intervention: Collective Advocacy (CA)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Group Intervention (GI)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: Individual Counselling (IC)
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: CA + IC + GI sequence
Number of subjects: 752

Group type: EXPERIMENTAL
Intervention: GI + CA + IC sequence
Number of subjects: 752
Study: 35298778

Group type: EXPERIMENTAL
Intervention: DR-BNI intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 34216139

Group type: EXPERIMENTAL
Intervention: High-Frequency Transcranial Magnetic Stimulation (HF-TMS), 2-week intervention (five 20-minute sessions/week)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Physical Exercise (PE), 8-week low-intensity program (two 60-minute sessions/week)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control Group (CG), no intervention
Number of subjects: 49
Study: 32528665

Group type: EXPERIMENTAL
Intervention: Text message arm
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care (control) arm
Number of subjects: 200
Study: 35739371

Group type: COMPARATOR
Intervention: Video lecture
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Self-training (video lecture + self-performed FOCUS)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Overall (self-learning followed by telepresence instruction)
Number of subjects: 24
Study: 34130360

Group type: EXPERIMENTAL
Intervention: Medium-power (MP) laser device (50 W) at 39.6 W (2.2 J/18 Hz)
Number of subjects: 120

Group type: COMPARATOR
Intervention: High-power (HP) laser device (100 W) at 42 W (1.2 J/35 Hz)
Number of subjects: 120
Study: 36066447

Group type: EXPERIMENTAL
Intervention: Cathodal HD-tDCS targeting the ACC
Number of subjects: 66

Group type: COMPARATOR
Intervention: Anodal HD-tDCS targeting the ACC
Number of subjects: 66

Group type: COMPARATOR
Intervention: Sham HD-tDCS
Number of subjects: 66
Study: 33030020

Group type: EXPERIMENTAL
Intervention: Topical 1:1000 epinephrine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Topical 1:10 000 epinephrine
Number of subjects: 19
Study: 35187992

Group type: EXPERIMENTAL
Intervention: Financial incentive (∼$10 USD)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 215
Study: 34624930

Group type: EXPERIMENTAL
Intervention: Total Ankle Replacement (TAR)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Ankle Fusion (AF)
Number of subjects: 19
Study: 32703593

Group type: EXPERIMENTAL
Intervention: TiNO-coated stent
Number of subjects: 1491

Group type: COMPARATOR
Intervention: EES
Number of subjects: 1491
Study: 35123476

Group type: EXPERIMENTAL
Intervention: Workplace strengthening exercise program
Number of subjects: 166

Group type: COMPARATOR
Intervention: Control group (ergonomic guidance only)
Number of subjects: 166
Study: 34014690

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated briefer versions of each instrument (self-efficacy, coping strategies, anxiety, depression)
Number of subjects: 0
Study: 32189446

Group type: EXPERIMENTAL
Intervention: Simulation-based training (SBT)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Non-simulation-based training (NSBT)
Number of subjects: 47
Study: 35972259

Group type: EXPERIMENTAL
Intervention: MiniMed 780G advanced hybrid closed loop (AHCL) system
Number of subjects: 41

Group type: COMPARATOR
Intervention: MDI+BGM
Number of subjects: 41